Skip to search formSkip to main contentSkip to account menu

Bidil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
June 2007 marked the second anniversary of the Food and Drug Administration (FDA)’s approval of BiDil, the first drug to be… 
Review
2008
Review
2008
In a recent discussion about how scientific knowledge might potentially change our understanding of the nature and extent of… 
Highly Cited
2007
Highly Cited
2007
Considerable discussion has followed the FDA approval in June 2005 of BiDil, a fixed-dose combination of isosorbide dinitrate, 20… 
2007
2007
In 2005, the U.S. Food and Drug Administration (FDA) approved BiDil (NitroMed, Lexington, Massachusetts), a combination of 2… 
Review
2007
Review
2007
BiDil is a new fixed-dose combination of 2 older medications, isosorbide dinitrate (ISDN) and hydralazine. ISDN is an organic… 
Highly Cited
2006
Highly Cited
2006
Isosorbide and hydralazine in a fixed-dose combination (BiDil) has provoked controversy as the first drug approved by the Food… 
Review
2006
Review
2006
This article endeavors to place into context recent developments surrounding the United States Food and Drug Administration… 
2006
2006
In a recent Health Affairs Web Exclusive, Pamela Sankar and Jonathan Kahn argue against the Food and Drug Administration's… 
2005
2005
Approval of 'race-based' drug is stimulating efforts to detect and predict true subgroups for drug response 
Review
2004
Review
2004
A drug called BiDil is poised to become the first drug ever approved by the Food and Drug Administration (FDA) to treat heart…